Prostate Cancer - Results from #26360

Prognostic determinants in prostate cancer - Abstract February 2, 2012

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract February 2, 2012

α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract February 2, 2012

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract February 2, 2012

Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk - Abstract February 2, 2012

Implications of treatment on body image and quality of life - Abstract February 1, 2012

Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: Time reduction and cost benefit - Abstract February 1, 2012

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy - Abstract February 1, 2012

Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age - Abstract February 1, 2012

Treatment given near the end of life in castration-resistant prostate cancer - Abstract February 1, 2012

Lymph node staging with choline PET/CT in patients with prostate cancer: A review - Abstract February 1, 2012

Paraneoplastic neurological and hematological syndromes associated with prostate cancer - Abstract February 1, 2012

Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy - Abstract February 1, 2012

Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes - Abstract February 1, 2012

Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer - Abstract February 1, 2012

Intermittent androgen deprivation in advanced prostate cancer - A review - Abstract February 1, 2012

B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer - Abstract February 1, 2012

Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth - Abstract February 1, 2012

Modeling a lethal prostate cancer variant with small-cell carcinoma features - Abstract February 1, 2012

Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer February 1, 2012

Page 1319 of 1436